Latest Trials
| EudraCT Number: 2010-022941-72 | Sponsor Protocol Number: PMR-EC-1503 | Start Date: | |||||||||||
| Sponsor Name: Astellas Pharma Europe Ltd. | |||||||||||||
| Full Title: A MULTICENTER, TWO ARM, RANDOMIZED, OPEN LABEL CLINICAL STUDY TO COMPARE RENAL FUNCTION IN STABLE HEART TRANSPLANT RECIPIENTS RECEIVING AN ADVAGRAF® BASED IMMUNOSUPPRESSIVE REGIMEN WITH OR WITHOUT ... | |||||||||||||
| Medical condition: Prophylaxis of heart transplant rejection. | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: AT (Prematurely Ended) SK (Prematurely Ended) CZ (Prematurely Ended) ES (Prematurely Ended) | |||||||||||||
| Trial results: View results | |||||||||||||